Author

Si Xuan 1

1 AbbVie Inc., North Chicag

MATCHING-ADJUSTED INDIRECT COMPARISONOF UPADACITINIB VERSUS VEDOLIZUMAB AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Walter Reinisch, Severine Vermeire, Charlotte Hedin, David T. Rubin, Julian Panés, Huiwen Deng, Si Xuan, Lani Wegrzyn, John Liu, Dapo Ilo, Wen Zhou, Yuri Sanchez Gonzalez, Remo Panaccione

Item 1 - 1 / 1
1